Site US10030 — Chicago, Illinois

Site US10030 is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10030 has participated in 1 clinical trials.

Therapeutic areas: Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10030?

Site US10030 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10030 conducted?

Site US10030 has 1 clinical trials on record. Their work covers Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients.

Is Site US10030 accredited by Crixeo Health?

Site US10030 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10030?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.